These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9288789)
1. Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma. Takano T; Matsuzuka F; Sumizaki H; Kuma K; Amino N Cancer Res; 1997 Sep; 57(17):3792-7. PubMed ID: 9288789 [TBL] [Abstract][Full Text] [Related]
2. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Takano T; Miyauchi A; Yokozawa T; Matsuzuka F; Maeda I; Kuma K; Amino N Cancer Res; 1999 Sep; 59(18):4542-5. PubMed ID: 10493503 [TBL] [Abstract][Full Text] [Related]
3. [Molecular-based diagnosis of thyroid carcinomas by detecting cancer-specific mRNAs]. Takano T; Amino N Rinsho Byori; 2000 Feb; 48(2):149-54. PubMed ID: 10804818 [TBL] [Abstract][Full Text] [Related]
4. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer. Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345 [TBL] [Abstract][Full Text] [Related]
5. Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma. Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A Jpn J Clin Oncol; 2007 Sep; 37(9):647-51. PubMed ID: 17704536 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization. Tanaka K; Inoue H; Miki H; Komaki K; Monden Y Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520 [TBL] [Abstract][Full Text] [Related]
7. Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. Takano T; Miyauchi A; Yokozawa T; Matsuzuka F; Liu G; Higashiyama T; Morita S; Kuma K; Amino N Cancer Res; 1998 Nov; 58(21):4913-7. PubMed ID: 9809999 [TBL] [Abstract][Full Text] [Related]
8. Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid. Arai T; Watanabe M; Onodera M; Yamashita T; Masunaga A; Itoyama S; Itoh K; Sugawara I Am J Pathol; 1993 Jun; 142(6):1938-44. PubMed ID: 8389529 [TBL] [Abstract][Full Text] [Related]
9. Detection of androgen receptor (AR) mRNA by the reverse transcription polymerase chain reaction (RT-PCR) in human thyroids. Franceschetti P; Rossi R; Aguiari GL; degli Uberti E; del Senno L Boll Soc Ital Biol Sper; 1993 Jan; 69(1):21-4. PubMed ID: 8329186 [TBL] [Abstract][Full Text] [Related]
11. Expression of parathyroid hormone-related peptide in human thyroid tumours. Nakashima M; Ohtsuru A; Luo WT; Nakayama T; Enomoto H; Usa T; Kiriyama T; Ito M; Nagataki S; Yamashita S J Pathol; 1995 Feb; 175(2):227-36. PubMed ID: 7738719 [TBL] [Abstract][Full Text] [Related]
13. [Aspiration biopsy-RT-PCR(ABRP): lesson from its success]. Takano T; Amino N Rinsho Byori; 2001 Dec; 49(12):1248-54. PubMed ID: 11797396 [TBL] [Abstract][Full Text] [Related]
14. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634 [TBL] [Abstract][Full Text] [Related]
15. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma. de Souza Meyer EL; Dora JM; Wagner MS; Maia AL Clin Endocrinol (Oxf); 2005 Jun; 62(6):672-8. PubMed ID: 15943828 [TBL] [Abstract][Full Text] [Related]
16. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias. Chiappetta G; Ferraro A; Vuttariello E; Monaco M; Galdiero F; De Simone V; Califano D; Pallante P; Botti G; Pezzullo L; Pierantoni GM; Santoro M; Fusco A Eur J Cancer; 2008 May; 44(7):1015-21. PubMed ID: 18375116 [TBL] [Abstract][Full Text] [Related]
18. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization. Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930 [TBL] [Abstract][Full Text] [Related]
19. Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction. Higashiyama T; Takano T; Matsuzuka F; Liu G; Miyauchi A; Yokozawa T; Morita S; Kuma K; Shiba E; Noguchi S; Amino N Thyroid; 1999 Mar; 9(3):235-40. PubMed ID: 10211598 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer. Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]